Hepatoprotective Drugs for the Treatment of Virus-Induced Chronic Hepatitis: From Hypercarcinogenic State to Hypocarcinogenic State.

The Japanese Journal of Pharmacology
doi 10.1254/jjp.87.177
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Pharmacological Society

Related search

Treatment Options for Chronic Hepatitis C Virus Infection

Medicinski Pregled
Medicine
2006English

Boceprevir in the Treatment of Chronic Hepatitis C Virus Infection

Virus Adaptation and Treatment
VirologyInfectious DiseasesImmunology
2011English

State-Of-The-Art Acute and Chronic GVHD Treatment

International Journal of Hematology
Hematology
2015English

Treatment of Chronic Hepatitis B Virus Infection With Rebavrin.

BMJ
1977English

Treatment Effect of a Flavonoid Prescription on Duck Virus Hepatitis by Its Hepatoprotective and Antioxidative Ability

Pharmaceutical Biology
Molecular MedicinePharmacologyComplementaryAlternative MedicinePharmaceutical ScienceMedicineDrug Discovery
2016English

The Hepatitis C Awareness Through to Treatment (HepCATT) Study: Improving the Cascade of Care for Hepatitis C Virus-Infected People Who Inject Drugs in England

Addiction
MedicinePsychiatryMental Health
2019English

Points: Antiviral Treatment in Chronic Infection With Hepatitis B Virus

BMJ
1986English

Gene Expression Profiling to Predict and Assess the Consequences of Therapy-Induced Virus Eradication in Chronic Hepatitis C Virus Infection

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2014English

Pin87 - Physician Preferences for the Treatment of Chronic Hepatitis C Virus Infection: An Adaptive Conjoint Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy